Investigation of Blood Glucose and Insulin Response After Intake of Vitalose

Not Applicable

Completed

• Conditions: Healthy Adults

• Registration Number: NCT04596709
• Lead Sponsor: Beneo-Institute

Brief Summary

The aim of this study is to assess the postprandial glucose and insulin response of Vitalose.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2020-09-28
• Study First Submitted QC: 2020-10-20
• Study Start: 2020-10-22
• Study First Posted: 2020-10-22
• Status Verified: 2020-12
• Primary Completion: 2020-12-01
• Study Completion: 2020-12-01
• Last Update Submitted: 2020-12-03
• Last Update Posted: 2020-12-07

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 13

Inclusion Criteria

• healthy adults
• Age 18-50 years
• BMI ≥18.5 and ≤30.0 kg/m²

Exclusion Criteria

• acute or chronic disease
• food allergy or intolerance
• intake of medications which affect glucose tolerance

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: CROSSOVER

Primary Outcome Measures

Name	Time	Method
2h iAUC for pp glucose response	Baseline, 15, 30, 45, 60, 90, 120 minutes
2h iAUC for pp insulin response	Baseline, 15, 30, 45, 60, 90, 120 minutes

Trial Locations

Locations (1)

BioTeSys GmbH; 🇩🇪 Esslingen, Germany